- Accredited hospitals have higher rates of complete tumor removal with negative surgical margins for rectal cancer patients.
- A new study found that 87% of patients at accredited centers achieved cancer-free margins, compared to 76% at non-accredited facilities.
- The study analyzed over 10,000 rectal cancer surgeries across the United States between 2018 and 2021.
- Accredited centers consistently achieve better outcomes and cleaner margins due to rigorous protocols and multidisciplinary checks.
- The disparity in outcomes highlights the importance of seeking care at a hospital with specialized accreditation for rectal cancer surgery.
In a sterile operating room in suburban Chicago, a surgeon leans over a patient, guiding a laparoscope with precision honed over decades. The mission: remove a malignant tumor nestled in the rectum without leaving behind a single cancerous cell. Yet miles away, in a smaller hospital without specialized accreditation, a similar surgery may unfold with less rigorous protocols, fewer multidisciplinary checks, and a higher chance of microscopic disease remaining. This disparity isn’t just logistical—it’s lifesaving. A new study reveals that where a patient undergoes rectal cancer surgery can dramatically affect whether the disease returns, with accredited centers consistently achieving cleaner margins and better outcomes.
Cancer-Free Margins More Common at Accredited Centers
According to research published in the Journal of the American College of Surgeons, patients treated at hospitals accredited by the American College of Surgeons’ National Accreditation Program for Rectal Cancer (NAPRC) were significantly more likely to have complete removal of tumors with negative surgical margins—meaning no cancer cells detected at the edge of the resected tissue. The study analyzed over 10,000 rectal cancer surgeries across the United States between 2018 and 2021, comparing outcomes from NAPRC-accredited and non-accredited centers. At accredited hospitals, 87% of patients achieved negative margins, compared to just 76% at non-accredited facilities. This 11-point gap translates into a substantially lower risk of local recurrence, a key predictor of long-term survival. The study also found that accredited centers were more likely to follow multimodal treatment protocols, including preoperative chemotherapy and radiation, and to conduct routine multidisciplinary tumor board reviews.
The Rise of Standardized Rectal Cancer Care
The push for standardized rectal cancer care emerged from decades of inconsistent outcomes. In the early 2000s, studies in the U.S. and Europe revealed wide variations in surgical quality, with some hospitals leaving tumor cells behind in up to 30% of cases. In response, countries like Sweden and the Netherlands implemented national quality programs that centralized complex cancer surgeries, resulting in marked improvements. The U.S. lagged, but in 2017, the American College of Surgeons launched the NAPRC to bring similar rigor stateside. The program mandates that accredited hospitals meet over 30 standards, including surgeon volume requirements, access to advanced imaging, immediate pathological review during surgery, and structured follow-up care. While initially adopted slowly, the program has now accredited more than 250 hospitals nationwide—just a fraction of the thousands performing rectal cancer surgery, but a growing force in reshaping care.
The Surgeons, Teams, and Institutions Driving Change
At the heart of the NAPRC’s success are multidisciplinary teams—surgeons, oncologists, radiologists, pathologists, and nurses—who collaborate before, during, and after surgery. Dr. Jennifer K. Smith, a surgical oncologist at an accredited center in Atlanta and a member of the NAPRC advisory board, explains that the accreditation process “forces institutions to confront gaps in care they might otherwise overlook.” Surgeons at these centers must perform a minimum number of rectal cancer procedures annually, ensuring proficiency. Hospitals must also track and report outcomes, fostering a culture of accountability. For patients, this means access to coordinated care pathways where decisions are made collectively, not in isolation. “It’s not just about technical skill,” Smith says, “it’s about systems that catch errors before they happen.”
Implications for Patients and the Healthcare System
For patients, the findings underscore a stark reality: choosing the right hospital can be as critical as the treatment itself. Those treated at non-accredited centers face higher odds of incomplete resection, which often leads to repeat surgeries, increased risk of metastasis, and greater emotional and financial toll. From a systemic perspective, the data support policies that steer complex cancer care toward high-volume, accredited centers—similar to how trauma and stroke care are regionalized. Insurers and referral networks may begin using accreditation status as a benchmark for coverage and recommendations. However, access remains a challenge, especially in rural areas where accredited centers are scarce. Telemedicine and satellite tumor boards offer partial solutions, but they can’t replace on-site expertise during surgery.
The Bigger Picture
This study adds to a growing body of evidence that healthcare outcomes are not just about individual skill but institutional infrastructure. The success of the NAPRC mirrors improvements seen in cardiac surgery and organ transplantation, where centralization and standardization reduced complications and saved lives. In an era where medical technology advances rapidly, the human and organizational elements of care are equally vital. Rectal cancer, once treated with widely varying success, is now a model for how structured quality programs can close gaps in care. The implications extend beyond one disease—suggesting that accreditation and accountability should be the norm, not the exception, in complex surgical care.
As the NAPRC continues to expand, researchers will monitor long-term survival data to further validate its impact. Meanwhile, patients facing rectal cancer surgery should ask one critical question: Is my hospital NAPRC-accredited? The answer could shape their prognosis. With more hospitals adopting these rigorous standards—and more patients seeking them out—the vision of equitable, high-quality cancer care moves closer to reality.
Source: MedicalXpress